AAAS Congressional Fellow 1994-1995. Executive Director of the Association of Clinical Research Organizations (ACRO) since the Association was founded in 2002. Steering Committee member Clinical Trials Transformation Initiative.
William Sharbaugh, PPD, United States
Josef von Rickenbach, PAREXEL International, United States
Paula Brown Stafford is President, Clinical Development at Quintiles Transnational. She has been with Quintiles for 26 years, holding numerous positions in Sales, Operations, and General Management. She holds a BSPH and MPH from the University of North Carolina at Chapel Hill.
John Watson, Covance Inc., United States
Jeffrey McMullen, PharmaNet/i3, an inVentiv Health Company, United States
Hear from top executives as they share their vision for the future of pharmaceutical development. What will it look like in five years, and how do we get there? What trends do we see? Have we seen the end of risk- and equity-sharing models in partnering? What are the pressures of private versus public ownership?
The panelists will answer questions and make comments on various facets of the industry in this moderator-led roundtable discussion. DIA will collect questions that are submitted in advance to share with the panel. Submit your question to firstname.lastname@example.org, Subject: Collaborative Partnerships.
Describe the trends that are being seen in pharmaceutical development
Discuss the pressures associated with private versus public ownership.
Audio Synchronized to PowerPoint